HCA Healthcare (HCA) last issued guidance on April 24, 2026 for fiscal year 2026. The company guided earnings per share in the range of $29.10 - $31.50, compared to a consensus EPS estimate of $30.30. HCA Healthcare also guided revenue in the range of $76.50B - $80.00B for the period.
Compared to prior guidance, HCA Healthcare maintained its EPS outlook from a previous range of $29.10 - $31.50. On the revenue side, the company maintained its revenue forecast from a prior range of $76.50B - $80.00B.
HCA Healthcare has issued 14 guidance updates between January 27, 2023 and April 24, 2026. During this period, the company raised its outlook 8 times, reflecting management's growing confidence in business performance.
Review all historical guidance issued by HCA Healthcare, including EPS and revenue forecasts across quarterly and annual periods.
The most recent guidance for HCA Healthcare (HCA) was reported on April 24, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $29.10 to $31.50, compared to the estimated EPS of $30.30. Additionally, HCA Healthcare forecasted revenue between $76.50B and $80.00B for the period.
HCA Healthcare (HCA) guided EPS in the range of $29.10 to $31.50 for the fiscal year 2026. The consensus analyst EPS estimate is $30.30.
HCA Healthcare (HCA) guided revenue in the range of $76.50B to $80.00B for the fiscal year 2026.
HCA Healthcare (HCA) maintained its EPS guidance from a prior range of $29.10 - $31.50 to $29.10 - $31.50 for the fiscal year 2026.
HCA Healthcare (HCA) last issued guidance on April 24, 2026 for the fiscal year 2026.